Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis
Yoshiji, H, Kuriyama, S, Yoshii, J, Ikenaka, Y, Noguchi, R, Hicklin, D J, Wu, Y, Yanase, K, Namisaki, T, Yamazaki, M, Tsujinoue, H, Imazu, H, Masaki, T, Fukui, H
Published in Gut (01.09.2003)
Published in Gut (01.09.2003)
Get full text
Journal Article
Antifibrotic Effects of Combined Treatment with Farnesoid X Receptor Agonist and Angiotensin-II Type1 Receptor Blocker on Hepatic Fibrogenesis in the Rat Model of Nonalcoholic Steatohepatitis
Namisaki, T, Okura, Y, Sato, S, Noguchi, R, Moriya, K, Kitade, M, Takeda, K, Nishimura, N, Sawada, Y, Seki, K, Kawaratani, H, Kaji, K, Yoshiji, H
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
Impact of the Combination of Dipeptidyl Peptidase IV Inhibitor and Angiotensin-II Type 1 Receptor Blocker on Hepatocarcinogenesis in a Rat Model of Nonalcoholic Steatohepatitis
Okura, Y, Namisaki, T, Noguchi, R, Takeda, K, Moriya, K, Kitade, M, Nishimura, N, Sato, S, Sawada, Y, Kawaratani, H, Seki, K, Kaji, K, Yoshiji, H
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in mice
Yoshiji, H, Kuriyama, S, Noguchi, R, Yoshii, J, Ikenaka, Y, Yanase, K, Namisaki, T, Kitade, M, Uemura, M, Masaki, T, Fukui, H
Published in Gut (01.12.2005)
Published in Gut (01.12.2005)
Get full text
Journal Article
Two cases of colonic tuberculosis presenting with massive melena
Namisaki, T., Yoshiji, H., Fujimoto, M., Kojima, H., Yanase, K., Kitade, M., Ikenaka, Y., Toyohara, M., Yamao, J., Tsujimoto, T., Tsuruzono, T., Kitano, H., Matsumura, K., Matsumura, Y., Fukui, H.
Published in International journal of clinical practice (Esher) (01.12.2004)
Published in International journal of clinical practice (Esher) (01.12.2004)
Get full text
Journal Article
Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity
Kaji, Kosuke, Takaya, Hiroaki, Saikawa, Soichiro, Furukawa, Masanori, Sato, Shinya, Kawaratani, Hideto, Kitade, Mitsuteru, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Mitoro, Akira, Yoshiji, Hitoshi
Published in World journal of gastroenterology : WJG (21.12.2017)
Published in World journal of gastroenterology : WJG (21.12.2017)
Get full text
Journal Article
Moderate alcohol consumption protects against fatty liver in males
Akahane, T., Namisaki, T., Kitade, M., Kaji, K., Takaya, H., Shimozato, N., Sato, S., Yoshiji, H.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
SAT-526 - Moderate alcohol consumption protects against fatty liver in males
Akahane, T., Namisaki, T., Kitade, M., Kaji, K., Takaya, H., Shimozato, N., Sato, S., Yoshiji, H.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
THU-223 - Effect of nalfurafine hydrochloride for refractory pruritus in patients with primary biliary cholangitis: a multicenter, post-marketing, single-arm, prospective study
Yagi, M., Tanaka, A., Namisaki, T., Abe, M., Takahashi, A., Honda, A., Matsuzaki, Y., Ohira, H., Yoshiji, H., Takikawa, H.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
Effect of nalfurafine hydrochloride for refractory pruritus in patients with primary biliary cholangitis: a multicenter, post-marketing, single-arm, prospective study
Yagi, M., Tanaka, A., Namisaki, T., Abe, M., Takahashi, A., Honda, A., Matsuzaki, Y., Ohira, H., Yoshiji, H., Takikawa, H.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
Is patient-reported outcome improved by nalfurafine hydrochloride in patients with primary biliary cholangitis and refractory pruritus? A post-marketing, single-arm, prospective study
Yagi, Minami, Tanaka, Atsushi, Namisaki, Tadashi, Takahashi, Atsushi, Abe, Masanori, Honda, Akira, Matsuzaki, Yasushi, Ohira, Hiromasa, Yoshiji, Hitoshi, Takikawa, Hajime
Published in Journal of gastroenterology (01.10.2018)
Published in Journal of gastroenterology (01.10.2018)
Get full text
Journal Article
Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity
Takaya, H., Kaji, K., Saikawa, S., Furukawa, M., Sato, S., Sawada, Y., Kawaratani, H., Kitade, M., Moriya, K., Namisaki, T., Akahane, T., Mitoro, A., Yoshiji, H.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
THU-215 - Biochemical response to ursodeoxycholic acid predicts histologic primary biliary cholangitis progression
Namisaki, T., Fujinaga, Y., Moriya, K., Kitade, M., Kaji, K., Kawaratani, H., Seki, K., Takaya, H., Sato, S., Sawada, Y., Akahane, T., Yoshiji, H.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
Biochemical response to ursodeoxycholic acid predicts histologic primary biliary cholangitis progression
Namisaki, T., Fujinaga, Y., Moriya, K., Kitade, M., Kaji, K., Kawaratani, H., Seki, K., Takaya, H., Sato, S., Sawada, Y., Akahane, T., Yoshiji, H.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
SAT-320 - Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity
Takaya, H., Kaji, K., Saikawa, S., Furukawa, M., Sato, S., Sawada, Y., Kawaratani, H., Kitade, M., Moriya, K., Namisaki, T., Akahane, T., Mitoro, A., Yoshiji, H.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
THU-454 - Effect of combined farnesoid X receptor agonist (INT747) and dipeptidyl peptidase-4 inhibitor (sitagliptin) on liver fibrosis
Shimozato, N., Namisaki, T., Akahane, T., Moriya, K., Kitade, M., Kawaratani, H., Kaji, K., Okura, Y., Takaya, H., Sawada, Y., Nishimura, N., Sato, S., Saikawa, S., Seki, K., Furukawa, M., Kubo, T., Yoshiji, H.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
Effect of combined farnesoid X receptor agonist (INT747) and dipeptidyl peptidase-4 inhibitor (sitagliptin) on liver fibrosis
Shimozato, N., Namisaki, T., Akahane, T., Moriya, K., Kitade, M., Kawaratani, H., Kaji, K., Okura, Y., Takaya, H., Sawada, Y., Nishimura, N., Sato, S., Saikawa, S., Seki, K., Furukawa, M., Kubo, T., Yoshiji, H.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
Clustering Reveals the Prognostic Role of Serum Albumin Values Within the Normal Range in Patients with Primary Biliary Cholangitis
Gerussi, A., Verda, D., Bernasconi, D.P., Carbone, M., Komori, A., Abe, M., Inao, M., Namisaki, T., Mochida, S., Yoshiji, H., Hirschfield, G., Lindor, K., Pares, A., Corpechot, C., Cazzagon, N., Floreani, A., Marzioni, M., Alvaro, D., Vespasiani-Gentilucci, U., Cristoferi, L., Valsecchi, M.G., Muselli, M., Study Group, the Japan PBC, Study Group, the Global PBC, study Group, the Italian PBC, Hansen, B.E., Tanaka, A., Invernizzi, P.
Published in Digestive and liver disease (01.03.2021)
Published in Digestive and liver disease (01.03.2021)
Get full text
Journal Article
FRI-097 - Impact of the Combination of Dipeptidyl Peptidase IV Inhibitor and Angiotensin-II Type 1 Receptor Blocker on Hepatocarcinogenesis in a Rat Model of Nonalcoholic Steatohepatitis
Okura, Y., Namisaki, T., Noguchi, R., Takeda, K., Moriya, K., Kitade, M., Nishimura, N., Sato, S., Sawada, Y., Kawaratani, H., Seki, K., Kaji, K., Yoshiji, H.
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
SAT-336 - Antifibrotic Effects of Combined Treatment with Farnesoid X Receptor Agonist and Angiotensin-II Type1 Receptor Blocker on Hepatic Fibrogenesis in the Rat Model of Nonalcoholic Steatohepatitis
Namisaki, T., Okura, Y., Sato, S., Noguchi, R., Moriya, K., Kitade, M., Takeda, K., Nishimura, N., Sawada, Y., Seki, K., Kawaratani, H., Kaji, K., Yoshiji, H.
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article